Clinical Trial Results:
A randomized, single-blinded, multicenter, phase IV study to compare systemic VEGF protein dynamics following monthly intravitreal injections of 0.5 mg ranibizumab versus 2 mg aflibercept until study week 12 in patients with visual impairment due to diabetic macular edema
Summary
|
|
EudraCT number |
2014-001639-35 |
Trial protocol |
DE IT |
Global completion date |
02 Jul 2012
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v2(current) |
This version publication date |
02 Dec 2019
|
First version publication date |
01 Nov 2019
|
Other versions |
v1 |
Version creation reason |
|
Summary report(s) |
cancellation letter for CRFB002DDE25 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.